Objectives: Zinc metabolism is frequently abnormal in renal allograft
recipients. These abnormalities may be immune mediated because zinc me
tabolism is affected by inflammation. Methods: We determined urinary z
inc and neopterin concentrations in 24 allograft recipients (18 kidney
, 3 combined kidney-pancreas and 3 liver allografts) daily for 1-41 da
ys. In addition, serum zinc concentrations were measured in 11 patient
s. Results: Serum zinc was decreased and urinary zinc concentrations w
ere increased in kidney as well as liver transplant recipients when co
mpared with healthy controls. Urinary zinc concentrations were only sl
ightly elevated in patients with uncomplicated post-transplant course,
but the increase was more pronounced in renal allograft recipients wi
th acute tubular necrosis. Urinary zinc concentrations were drasticall
y increased during rejection of various organs. In addition, significa
nt associations between urinary zinc and neopterin concentrations were
observed. Conclusion: Our results suggest that enhanced urinary zinc
excretion in allograft recipients is due to immune activation. The dat
a indicate that cytokines play a role in zinc metabolism.